Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biophytis SA | 1.2M | 0.0x | --- |
Pharmagreen Biotech Inc | 1.3M | -2.6x | --- |
Zyversa Therapeutics Inc | 1.2M | 0.0x | --- |
CohBar Inc | 1.5M | -0.1x | --- |
Ayala Pharmaceuticals Inc | 1.2M | 0.0x | --- |
GlucoTrack Inc | 1.5M | -0.1x | --- |
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 389.9K |
Biophytis SA does not pay a dividend. | |
Beta | 1.17 |
EPS | $-68.17 |
Book Value | --- |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.